StockGuru Spotlight on International Stem Cell Corp.
(Symbol: ISCO)
Help us update information on this company. Email any updates to: [email protected]
About International Stem Cell Corp.:
International Stem Cell Corporation is a California-based biotechnology company developing novel stem cell based therapies and biomedical products. ISCO’s core technology, parthenogenesis, creates pluripotent human stem cells from unfertilized eggs. These stem cells avoid ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenic, homozygous stem cell line that can be a source of therapeutic cells with minimal immune rejection after transplantation. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, and cell-based skin care products through its subsidiary Lifeline Skin Care.
Where it is located:
5950 Priestly Drive
Carlsbad, CA
92008
United States
Key Executive Contact:
Investor Relations
IR
Ninety Day Volume:
925971 (as of date of publication)
Ninety Day Dollar Volume:
$91,671
Share Information:
213590669 shares as of 2014-08-12
Corporate Information:
State Incorporated: DE
Country Incorporated: USA
Contact, Website and Social Media for International Stem Cell Corp.:
Shown Where Available
Website: http://www.internationalstemcell.com
Facebook: http://www.facebook.com/InternationalStemCellCorporation
Twitter: https://www.twitter.com/intlstemcell
LinkedIn: http://www.linkedin.com/company/international-stem-cell-corporation?trk=tabs_biz_home
Telephone: (760) 940-6383
Email: [email protected]
Investor Relations for International Stem Cell Corp.: